PROCAPAN Drug Patent Profile
✉ Email this page to a colleague
When do Procapan patents expire, and what generic alternatives are available?
Procapan is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PROCAPAN is procainamide hydrochloride. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procapan
A generic version of PROCAPAN was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROCAPAN?
- What are the global sales for PROCAPAN?
- What is Average Wholesale Price for PROCAPAN?
Summary for PROCAPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 100 |
| Patent Applications: | 1,413 |
| DailyMed Link: | PROCAPAN at DailyMed |
US Patents and Regulatory Information for PROCAPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panray | PROCAPAN | procainamide hydrochloride | CAPSULE;ORAL | 083553-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
